Novelcare vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionNovelcareIsomorphic Labs
PricingFreemium (zero cost to patients, revenue opportunity for providers)Contact-based (large pharma partnerships, undisclosed)
Target usersPrimary care physicians, specialists, clinical trial sitesLarge pharma companies, research institutions
Core technologyClinical trial matching platform, HIPAA-compliant workflowAI-driven drug design (AlphaFold, generative and predictive models)
IntegrationSeamless integration with clinical workflowDeep partnerships (Novartis, Johnson & Johnson), no public API
Revenue modelChart review revenue for providers, zero cost to patientsPartnership-based, undisclosed terms

For healthcare providers looking to offer clinical trial options and earn revenue, Novelcare is a practical, low-risk choice with a freemium model. For pharma companies needing AI-driven drug discovery at scale, Isomorphic Labs is unmatched but requires deep partnership and significant investment. They target entirely different buyers—choose based on whether your need is patient-facing trial access or molecule design.

Novelcare
Novelcare

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Freemium
Contact Sales
Plans
$0/mo
—
Popularity
4 views
7.5k views
Skill Level
Intermediate
Advanced
API Available
Platforms
—
—
Categories
🧬 Drug Discovery & Life Sciences🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
Clinical trial matching for physicians
Automatic patient notification when you flag a relevant patient
Fits into your existing clinical workflow without changes
HIPAA-compliant data handling with explicit boundaries
Revenue opportunity through chart review for some studies
Patient-facing treatment option discovery
Support for multiple therapeutic areas
Provider dashboard for managing patient study options
Secure data sharing with defined boundaries
Doctor-initiated patient identification for study eligibility
Patient stories covering depression and weight-related conditions
Demo walkthrough of the physician matching flow
Trust and HIPAA & Security documentation pages
Refer-a-patient entry point for physicians
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO

Who should pick which

  • Solo primary care physician
    Pick: Novelcare

    Freemium model and zero patient cost allow easy adoption; clinical trial matching adds treatment options without extra burden.

  • Pharma VP of Drug Discovery
    Pick: Isomorphic Labs

    AI-driven molecule design with AlphaFold and partnerships like J&J provide cutting-edge lead optimization for large programs.

  • Clinical trial site coordinator
    Pick: Novelcare

    Provider dashboard and automatic notifications streamline patient referral and enrollment management.

  • Research institution exploring AI in biology
    Pick: Isomorphic Labs

    Access to advanced AI models and digital biology simulation through collaborative partnerships.

Frequently Asked Questions

Novelcare vs Isomorphic Labs: which should you choose?

For healthcare providers looking to offer clinical trial options and earn revenue, Novelcare is a practical, low-risk choice with a freemium model. For pharma companies needing AI-driven drug discovery at scale, Isomorphic Labs is unmatched but requires deep partnership and significant investment. They target entirely different buyers—choose based on whether your need is patient-facing trial access or molecule design.

Can I use Novelcare without being a healthcare provider?

No, Novelcare requires a provider to facilitate trial matching; patients cannot access it directly.

Does Isomorphic Labs offer a public API or software?

No, Isomorphic Labs works exclusively through private partnerships with pharma companies.

What is the cost for patients using Novelcare?

Patients pay nothing; clinical trial participation is zero cost to them.

How does Isomorphic Labs generate revenue?

Through undisclosed partnership fees and milestone payments from pharma collaborations.

Is Novelcare HIPAA-compliant?

Yes, it offers HIPAA-compliant data handling with secure sharing boundaries.

What recent funding has Isomorphic Labs raised?

$600M external investment in 2025 and a Series B in February 2026 (undisclosed amount).

Can I integrate Novelcare with my existing EHR?

It integrates into clinical workflow but is not a full EHR replacement; specific integrations are not listed.

Which pharma companies partner with Isomorphic Labs?

Novartis and Johnson & Johnson, as per latest news.

More Novelcare or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026